LRRK2 expression and activity are enriched in immune cells, and LRRK2 mutations are common risk factors for both PD and IBD, placing LRRK2 at the intersection of the immune system, the intestine, and PD10,21,48–50. The gene discussed is LRRK2; the disease is inflammatory bowel disease.